Shanghai Yizhong Pharmaceutical Co., Ltd. (SHA:688091)
53.72
+2.22 (4.31%)
Mar 10, 2026, 11:29 AM CST
SHA:688091 Market Cap
SHA:688091 has a market cap or net worth of 10.58 billion as of March 9, 2026. Its market cap has increased by 41.11% in one year.
Market Cap
10.58B
Enterprise Value
10.09B
Revenue
317.08M
Ranking
n/a
PE Ratio
166.13
Stock Price
53.72
Market Cap Chart
Since September 9, 2021, SHA:688091's market cap has increased from 5.18B to 10.58B, an increase of 104.12%. That is a compound annual growth rate of 17.19%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 9, 2026 | 10.58B | 9.57% |
| Dec 31, 2025 | 9.66B | 17.68% |
| Dec 31, 2024 | 8.20B | -19.01% |
| Dec 29, 2023 | 10.13B | 0.86% |
| Dec 30, 2022 | 10.04B | 111.52% |
| Dec 31, 2021 | 4.75B | -8.39% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Tianjin Chase Sun Pharmaceutical Co.,Ltd | 10.78B |
| Beijing Foyou Pharma CO.,LTD | 10.89B |
| Zhejiang CONBA Pharmaceutical | 11.06B |
| Yantai Dongcheng Pharmaceutical Group | 10.46B |
| Wanbangde Pharmaceutical Holding Group | 10.37B |
| Mayinglong Pharmaceutical Group | 11.37B |
| Porton Pharma Solutions | 11.46B |
| Zhejiang Hisoar Pharmaceutical | 11.87B |